Biotech Investors & VC Firms
2107 firms in this list, with a median first check of $500K. 405 of them lead rounds. Generated from verified public data and updated continuously.
Cowin Capital Group
ShenzhenSeed–Late Stage$1.4M – $50M
11 people
Pathway to Cures
New YorkSeed–Series A
20 people
Sprout
Palmerston NorthPre-Seed–Seed
17 people
Time BioVentures
Southern CaliforniaSeed–Series A
17 people
Triventures
HerzliyaPre-Seed–Series A$1M – $3M
11 people
Waseda University Ventures
TokyoPre-Seed–Growth
8 people
America's Frontier Fund
ArlingtonPre-Seed–Growth$500K – $10M
13 people
Debiopharm Innovation Fund
LausannePre-Seed–Late Stage$1M – $5M
13 people
IDG Capital Vietnam
HanoiSeed–Late Stage$250K – $3M
13 people
Side Door Ventures
Fernandina BeachPre-Seed–Growth$300K – $5M
16 people
Bioventures Investors
WestboroughSeed–Late Stage$15M – $100M
15 people
Co-Win Ventures
SuzhouSeed–Series B
Cove Fund
IrvinePre-Seed–Series A$250K – $1M
12 people
Creator Fund
LondonPre-Seed–Series A$1.1M
21 people
Crescent Capital Partners
SydneySeries A–Late Stage$13.2M – $52.8M
18 people
Enterprise Investors Sp. z o. o.
WarsawSeries A–Growth$21.6M – $81M
24 people
Finance Yorkshire
BarnsleySeed–Growth
21 people
Genentech
South San Francisco
21 people
Grazia Equity GmbH
StuttgartSeed–Late Stage$540K – $2.7M
8 people
Revelation Partners
SausalitoGrowth–Late Stage$5M – $50M
17 people
Axial VC
San FranciscoPre-Seed–Series A$100K – $5M
2 people
Intuitive Ventures
SunnyvaleSeed–Series A
16 people
Kobe University Capital
KobePre-Seed–Growth
10 people
DNA Capital
São PauloPre-Seed–Late Stage$100K – $5M
15 people
Related lists
Investors & VC Firms in United States (5050)Crypto & Web3 Investors & VC Firms (4688)Investors & VC Firms in Global (4044)SaaS Investors & VC Firms (3602)AI & Machine Learning Investors & VC Firms (3577)Fintech Investors & VC Firms (3506)Healthtech Investors & VC Firms (3208)Enterprise Software Investors & VC Firms (3098)Investors & VC Firms in Europe (2833)Consumer Investors & VC Firms (2381)
Data sourced from public filings and firms' own websites — see our methodology.






































































